Business Standard

Page 16 - Pfizer

Pfizer seeks US govt approval to ease handling of Covid-19 vaccine

Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts

Pfizer seeks US govt approval to ease handling of Covid-19 vaccine
Updated On : 19 Feb 2021 | 9:10 PM IST

Pfizer submits data showing Covid vaccine's stability in refrigerators

If approved, this new storage option would offer pharmacies and vaccination centers greater flexibility in how they manage their vaccine supply

Pfizer submits data showing Covid vaccine's stability in refrigerators
Updated On : 19 Feb 2021 | 6:36 PM IST

Pfizer's Covid-19 vaccine supply to the EU 30% below plans: Report

Only about 2 million of those doses due in December have been delivered

Pfizer's Covid-19 vaccine supply to the EU 30% below plans: Report
Updated On : 17 Feb 2021 | 8:43 PM IST

Covid-19: Pfizer vaccine gets final nod in Japan, to be rolled out soon

Japan, however, was still the last country among the Group of Seven nations to give it the OK as it required an additional clinical trial to be conducted on Japanese people to ensure safety

Covid-19: Pfizer vaccine gets final nod in Japan, to be rolled out soon
Updated On : 15 Feb 2021 | 11:14 AM IST

Japan health panel recommends approval of Pfizer coronavirus vaccine

Health Minister Norihisa Tamura says a formal approval is expected Sunday

Japan health panel recommends approval of Pfizer coronavirus vaccine
Updated On : 12 Feb 2021 | 10:08 PM IST

US secures 200 million more doses of Moderna, Pfizer Covid-19 vaccines

The United States has secured an additional 200 doses of Moderna and Pfizer COVID-19 vaccines, President Joe Biden announced on Thursday (local time)."Just this afternoon, we signed the final contracts for 100 million more Moderna and 100 million more Pfizer vaccines. We're also able to move up the delivery dates with an additional 200 million vaccines to the end of July, faster than we expected and in further good news both companies agreed and we're now contractually obligated to expedite delivery of 100 million doses that were promised by the end of June to deliver them by the end of May," he said in an address to the National Institutes of Health.He also informed that the US is on track to have a vaccine supply for 300 million Americans by the end of July."Within three weeks, round the clockwork with so many people standing behind me and in front of me, we've now purchased enough vaccine supply to vaccinate all Americans, and now we're working to get those vaccines into the arms ..

US secures 200 million more doses of Moderna, Pfizer Covid-19 vaccines
Updated On : 12 Feb 2021 | 6:58 AM IST

Vaccine leadership, not chauvinism

The WHO's initiative to provide equitable access to vaccines - COVAX - is devoid of the funds needed to procure and supply the shots to poorer countries.

Vaccine leadership, not chauvinism
Updated On : 07 Feb 2021 | 10:55 PM IST
Updated On : 06 Feb 2021 | 2:27 AM IST

Pfizer retracts request for emergency approval of Covid-19 vaccine in India

Pfizer has not conducted any bridge trial on Indian population for its mRNA vaccine

Pfizer retracts request for emergency approval of Covid-19 vaccine in India
Updated On : 05 Feb 2021 | 12:51 PM IST

Covid-19: Pfizer withdraws Emergency Use Authorisation application in India

Pfizer had a meeting with India's drugs regulator on Wednesday and the decision was made after that, the company said.

Covid-19: Pfizer withdraws Emergency Use Authorisation application in India
Updated On : 05 Feb 2021 | 11:10 AM IST

AstraZeneca and Pfizer Covid-19 vaccines to be combined in Oxford trial

The Astra and Pfizer vaccines will be given in different orders and with two dosing intervals, four and 12 weeks apart.

AstraZeneca and Pfizer Covid-19 vaccines to be combined in Oxford trial
Updated On : 05 Feb 2021 | 1:11 AM IST

India to get around 97 million doses of AstraZeneca Covid-19 vaccine

As of now, Covax has not allotted the Pfizer-BioNTech vaccine for India.

India to get around 97 million doses of AstraZeneca Covid-19 vaccine
Updated On : 04 Feb 2021 | 9:44 AM IST

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax

As of now, Covax has not disclosed the India distribution plan for the Pfizer-BioNTech vaccine

India to get 97 million doses of Serum-made AstraZeneca vaccine from Covax
Updated On : 04 Feb 2021 | 9:38 AM IST

Pfizer forecasts about $15 billion in 2021 sales from Covid-19 vaccine

Pfizer is commanding a higher price for its vaccine than some rivals

Pfizer forecasts about $15 billion in 2021 sales from Covid-19 vaccine
Updated On : 03 Feb 2021 | 1:56 AM IST

France's Sanofi to help rival Pfizer-BioNTech make coronavirus vaccines

The announcement came as delays or production problems for the Pfizer-BioNTech vaccine and a vaccine from Britain''s AstraZeneca have caused political uproar across the European Union

France's Sanofi to help rival Pfizer-BioNTech make coronavirus vaccines
Updated On : 27 Jan 2021 | 10:08 PM IST

Five or six doses? Controversy over Pfizer Covid-19 vaccine vials

The difficulty in obtaining that sixth dose in practice means many countries are at loggerheads with Pfizer and facing a drop in supply.

Five or six doses? Controversy over Pfizer Covid-19 vaccine vials
Updated On : 27 Jan 2021 | 9:41 PM IST

Pfizer working on booster shot to protect against Covid-19 variants

"We are already laying the groundwork to respond quickly if a variant of SARS-CoV-2 shows evidence of escaping immunity by our vaccine," Pfizer said in an email to Reuters

Pfizer working on booster shot to protect against Covid-19 variants
Updated On : 27 Jan 2021 | 1:43 AM IST

WHO experts issue recommendations on Moderna's coronavirus vaccine

The guidance on Moderna came several weeks after issuing their recommendations on the rival Pfizer vaccine

WHO experts issue recommendations on Moderna's coronavirus vaccine
Updated On : 26 Jan 2021 | 8:00 PM IST

Syringes scarcity complicate US plan to squeeze more shots from Pfizer vial

The vaccine made by Pfizer and its German partner BioNTech , one of two authorized for U.S. emergency use, is shipped in vials initially indicated to hold five doses

Syringes scarcity complicate US plan to squeeze more shots from Pfizer vial
Updated On : 26 Jan 2021 | 8:07 AM IST

Pfizer wants India to order Covid-19 vaccine before pursuing nod

Pfizer says its application is supported by data from a global study that shows an overall efficacy rate of 95% with no vaccine-related, serious safety concerns

Pfizer wants India to order Covid-19 vaccine before pursuing nod
Updated On : 26 Jan 2021 | 12:06 AM IST